Maryland Company Gets $1.6 Billion for COVID-19 Vaccine Development
Novavax Inc., a biotechnology company based in Gaithersburg, Maryland, has received $1.6 billion from the federal government to develop a coronavirus vaccine. News4’s Jummy Olabanji reports.